Fairview Capital Partners
VC Fund
West Hartford, United States
Fairview Capital Partners is a VC fund in West Hartford focused on Health Care and Billing. We employ private market strategies that reflect the future and harness innovation
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $15M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Fairview Capital Partners invests in
Stages Fairview Capital Partners invests in
Countries Fairview Capital Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alan Mattamana
|
|||
|
Edwin Shirley
|
|||
Joann Price
|
|||
Kolawole Olofinboba
|
|||
Laurence Morse
|
|||
| See all 7 contacts → | |||
Investment Focus
Industry
- Health Care 2 (33%)
- Billing 1 (17%)
- FinTech 1 (17%)
- Payments 1 (17%)
- Software 1 (17%)
Stage
- Series B 3 (50%)
- Series A 1 (17%)
- Funding Round 1 (17%)
- Convertible Note 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alan Mattamana
Partner
|
Partner | Total investments: 0 | Find email | |
|
Edwin Shirley
Partner
|
Partner | Total investments: 0 | Find email | |
|
Joann Price
Co-founder
|
Co-founder | Total investments: 0 | Find email | |
|
Kolawole Olofinboba
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
|
Laurence Morse
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Inbox Health
|
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $20M / Sep 15, 2025 | |
|
Inbox Health
|
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $22.5M / Series B / May 04, 2023 | |
Covr Financial Technologies
|
About Covr Financial TechnologiesFounded in 2016, Covr offers a full suite of digital life insurance platforms, tools and planning services for financial institutions, including: Covr Advisor for financial advisors, Covr Consumer for offering insurance products directly to customers financial institutions and Covr Insights for inforce policymanagement. Covr currently serves over 24,000 financial advisors and 13 million customers across 30 financial institutions including wealth management firms, RIAs, IBDs, banks, credit unions, personal finance apps and P&C agencies. Covr’s investors include leading venture capital firms: Nyca Partners, Commerce Ventures, Allianz Life Ventures, Connectivity Capital Partners, Contour Venture Partners, Connecticut Innovations and Fairview Capital. Covr’s Advisory Board includes financial services leaders including Brian Finn, former president of Credit Suisse First Boston; Sallie Krawcheck, CEO of Elevest and formerly at Citigroup and Smith Barney; Hans Morris, managing partner, Nyca Partners, chairman of Lending Club, formerly president of Visa; Brady Dougan, former CEO of Credit Suisse; Gregg Fleming, CEO of Rockefeller Capital, Bob Kerzner, formerly CEO of LIMRA and Joe Plumeri, formerly of Smith Barney, FirstData and Willis Group. | $15M / Series B / Apr 07, 2022 | |
|
Inbox Health
|
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $15M / Series A / Apr 05, 2021 | |
|
Covr Financial Technologies
|
About Covr Financial TechnologiesFounded in 2016, Covr offers a full suite of digital life insurance platforms, tools and planning services for financial institutions, including: Covr Advisor for financial advisors, Covr Consumer for offering insurance products directly to customers financial institutions and Covr Insights for inforce policymanagement. Covr currently serves over 24,000 financial advisors and 13 million customers across 30 financial institutions including wealth management firms, RIAs, IBDs, banks, credit unions, personal finance apps and P&C agencies. Covr’s investors include leading venture capital firms: Nyca Partners, Commerce Ventures, Allianz Life Ventures, Connectivity Capital Partners, Contour Venture Partners, Connecticut Innovations and Fairview Capital. Covr’s Advisory Board includes financial services leaders including Brian Finn, former president of Credit Suisse First Boston; Sallie Krawcheck, CEO of Elevest and formerly at Citigroup and Smith Barney; Hans Morris, managing partner, Nyca Partners, chairman of Lending Club, formerly president of Visa; Brady Dougan, former CEO of Credit Suisse; Gregg Fleming, CEO of Rockefeller Capital, Bob Kerzner, formerly CEO of LIMRA and Joe Plumeri, formerly of Smith Barney, FirstData and Willis Group. | $7.5M / Convertible Note / Jun 01, 2020 | |
Rallybio
|
Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areasof hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. | $145M / Series B / Apr 14, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Fairview Capital Partners invest in?
Fairview Capital Partners invests primarily in Health Care, Billing and FinTech startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Fairview Capital Partners?
Public channels for Fairview Capital Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fairview Capital Partners?
The team at Fairview Capital Partners includes Alan Mattamana (Partner), Edwin Shirley (Partner) and Joann Price (Co-founder), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
